Medication info
Amadiem Tablets (Glimepiride)

Amadiem Tablets (Glimepiride)

Prescription medicationTabletOral
Ingredient · strength
Glimepiride›2mg / 1 tablet
Manufacturer / importer
Dongsung Pharmaceutical Co., Ltd.
Appearance
Green, oblong tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 200400894 · Notified 2004.11.19 · Insurance code 643200660

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
Adjust the dose individually for each patient. Swallow whole without chewing, with at least 1/2 cup of water. This medicine is taken orally once daily. Take it before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received medication, initiate treatment with 1 mg of glimepiride once daily. If necessary, increase the dose by 1 mg at 1- to 2-week intervals. In general, doses above 4 mg provide little additional benefit, although some patients have achieved better metabolic control when the dose was increased to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic drug. 2) Subsequent dose adjustment As diabetes control improves during treatment, the patient's requirement for this medicine may decrease. Therefore, dose reduction or discontinuation may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral hypoglycemic agent to this medicine There is no precise dose equivalence between this medicine and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this medicine, it is advisable to follow the instructions given under Initial Dose. That is, begin with 1 mg daily and adjust the dose at 1- to 2-week intervals. The potency and duration of action of the previous medication should be taken into account. 4) Dose adjustment during treatment While taking this medicine, blood glucose and/or urine glucose levels should be measured regularly. Regular measurement of glycated hemoglobin (HbA1c) levels is also recommended. In general, hypoglycemia is promptly controlled by immediate intake of sugar. Hypoglycemia may recur after treatment with a sulfonylurea, even if it was successfully managed initially. Therefore, patients should be monitored carefully. Severe hypoglycemia requires immediate medical treatment and follow-up, and hospitalization is sometimes necessary. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure, and is used when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal. Start insulin at a low dose and increase it approximately weekly according to fasting blood glucose measurements. Once stable, capillary blood glucose should be monitored daily whenever possible. Insulin doses should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. Clinical data have been published on combination therapy of metformin with other sulfonylureas, including glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the doses of each drug can be adjusted to achieve the desired blood glucose level. However, efforts should be made to determine the minimum effective dose of each drug for blood glucose control. There is a risk of hypoglycemia with concomitant administration of this medicine and metformin, and the risk may be increased. Appropriate precautions should be taken.

Ingredients

Manufacturer
Dongsung Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

  • Blood sugar control problems in patients with type 2 diabetes
View approved original text

This medication is used to assist in improving blood sugar control in patients with type 2 diabetes alongside dietary and exercise therapies. It can be administered alone and, in some cases, can be used in combination with other antihyperglycemic agents or insulin. Particularly, it can be used in combination with insulin when blood sugar control with oral antihyperglycemics is difficult or when monotherapy with sulfonylureas or metformin is ineffective, thus enhancing therapeutic effect. This medication helps effectively control the patient’s blood sugar.

How to take

Adult dose

Adjust the dose individually for each patient. Swallow whole without chewing, with at least 1/2 cup of water. This medicine is taken orally once daily. Take it before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received medication, initiate treatment with 1 mg of glimepiride once daily. If necessary, increase the dose by 1 mg at 1- to 2-week intervals. In general, doses above 4 mg provide little additional benefit, although some patients have achieved better metabolic control when the dose was increased to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic drug. 2) Subsequent dose adjustment As diabetes control improves during treatment, the patient's requirement for this medicine may decrease. Therefore, dose reduction or discontinuation may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral hypoglycemic agent to this medicine There is no precise dose equivalence between this medicine and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this medicine, it is advisable to follow the instructions given under Initial Dose. That is, begin with 1 mg daily and adjust the dose at 1- to 2-week intervals. The potency and duration of action of the previous medication should be taken into account. 4) Dose adjustment during treatment While taking this medicine, blood glucose and/or urine glucose levels should be measured regularly. Regular measurement of glycated hemoglobin (HbA1c) levels is also recommended. In general, hypoglycemia is promptly controlled by immediate intake of sugar. Hypoglycemia may recur after treatment with a sulfonylurea, even if it was successfully managed initially. Therefore, patients should be monitored carefully. Severe hypoglycemia requires immediate medical treatment and follow-up, and hospitalization is sometimes necessary. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure, and is used when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal. Start insulin at a low dose and increase it approximately weekly according to fasting blood glucose measurements. Once stable, capillary blood glucose should be monitored daily whenever possible. Insulin doses should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. Clinical data have been published on combination therapy of metformin with other sulfonylureas, including glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the doses of each drug can be adjusted to achieve the desired blood glucose level. However, efforts should be made to determine the minimum effective dose of each drug for blood glucose control. There is a risk of hypoglycemia with concomitant administration of this medicine and metformin, and the risk may be increased. Appropriate precautions should be taken.

Precautions

This medication should not be used in patients with insulin-dependent diabetes or in those suffering from diabetic ketoacidosis or coma. It should also be avoided by individuals who are allergic to this medication or to sulfonylurea agents, as well as those with severe liver or kidney dysfunction. It is not to be administered to pregnant or potentially pregnant women or to nursing mothers. Patients with severe infections or those who are pre- or post-surgery or have suffered major trauma are recommended to instead follow insulin therapy. Patients with gastrointestinal disorders may experience improper absorption of this medication, potentially leading to hypoglycemia, so caution is advised. Patients with genetic lactose intolerance or specific hereditary diseases should also avoid this medication. In the first week of taking this medication, there is an increased risk of hypoglycemia, so blood sugar should be checked frequently. Special caution is required for the elderly, individuals with poor nutritional status or irregular eating habits, and those who consume alcohol frequently. Individuals with weakened liver or kidney function may also respond more sensitively to this medication, so caution is necessary. If taking other medications, interaction may affect blood sugar control; therefore, it is essential to inform your doctor or pharmacist. Symptoms of hypoglycemia may occur, so it is important to be aware of these symptoms and to respond immediately. This medication may cause various side effects, including hypoglycemia, visual disturbances, digestive disorders, liver dysfunction, blood abnormalities, and allergic reactions. Notably, hypoglycemia symptoms may lead to headaches, severe hunger, nausea, fatigue, confusion, drowsiness, or loss of consciousness, so care should be taken. If an allergic reaction occurs, notify a doctor immediately, and in severe cases, discontinuation of the medication may be necessary. This medication should be taken alongside dietary and exercise therapies for blood sugar control, and regular intake is important. In the event of hypoglycemia, sugary foods should be consumed promptly to raise blood sugar. Regular blood sugar and urine sugar testing should be conducted during treatment to monitor the medication's efficacy. Care should be taken when driving or operating machinery due to the potential occurrence of hypoglycemia or impaired agility. Pregnant or nursing women should not take this medication, and transitioning to insulin therapy may be safer if necessary. In case of overdose, severe hypoglycemia may occur, so if overdose is suspected, immediate medical attention should be sought. This medication should be kept out of reach of children and stored in its original container.

Side effects

Hypoglycemia, headache, severe hunger, nausea, vomiting, fatigue, sleep, sleep disorders, anxiety, aggression, decreased concentration, decreased agility or activity, depression, confusion, language disorder, aphasia, visual impairment, tremors, incomplete paralysis, sensory disturbance, dizziness, weakness, loss of self-control, temporary mental confusion, seizures, drowsiness, loss of consciousness, coma, shallow breathing, bradycardia, sweating, cold and moist skin, tachycardia, hypertension, palpitations, angina, deep vein thrombosis, blurred vision, sensation of fullness in the upper abdomen, pressure sensation, abdominal pain, diarrhea, increased liver enzymes, liver dysfunction, biliary secretion disorder, jaundice, hepatitis, thrombocytopenia, leukopenia, hemolytic anemia, erythropenia, neutropenia, agranulocytosis, pancytopenia, itching, urticaria, rash, dyspnea, hypotension, shock, anaphylaxis, angioedema, Stevens-Johnson syndrome, allergic vasculitis, photosensitivity reaction of the skin, decreased serum sodium concentration, taste disorder, hair loss, weight gain, dizziness, liver dysfunction, abdominal pain, arthralgia, dyspepsia, facial edema, erectile dysfunction, flushing of the face, gastritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it must be stored in a tightly closed container. Additionally, it should be stored at room temperature between 1 to 30 degrees Celsius. Proper storage will help maintain the effectiveness of the medication.

Appearance and packaging

Appearance

Green, oblong tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.